Provided by Tiger Fintech (Singapore) Pte. Ltd.

Celanese

54.63
-2.2400-3.94%
Post-market: 54.630.00000.00%19:19 EDT
Volume:1.74M
Turnover:95.47M
Market Cap:5.98B
PE:-3.59
High:57.04
Open:55.58
Low:54.32
Close:56.87
Loading ...

Tandem Diabetes Care Gains CE Mark Approval

TIPRANKS
·
20 May

Celanese: Hold Rating Amid Macroeconomic Uncertainties and Debt Challenges with Potential Upside from Asset Sales

TIPRANKS
·
20 May

Celanese upgraded to Market Perform from Underperform at BMO Capital

TIPRANKS
·
20 May

Celanese Corp. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
20 May

Celanese Corp. Stock Underperforms Friday When Compared To Competitors Despite Daily Gains

Dow Jones
·
17 May

Celanese Is Maintained at Buy by B of A Securities

Dow Jones
·
16 May

Celanese price target raised to $61 from $55 at BofA

TIPRANKS
·
16 May

Celanese Corporation Held Annual Shareholder Meeting

Reuters
·
16 May

Press Release: Bioretec Ltd's business review Q1 2025: Strong net sales in the first quarter; CE approval with comprehensive indications received in January accelerates the future expansion of RemeOs products

Dow Jones
·
15 May

Celanese Corp. Stock Outperforms Competitors Despite Losses On The Day

Dow Jones
·
15 May

Celanese Corp. : Barclays Raises Target Price to $62 From $59

THOMSON REUTERS
·
14 May

Celanese Corp. Stock Underperforms Tuesday When Compared To Competitors

Dow Jones
·
14 May

Celanese Corp. Stock Underperforms Monday When Compared To Competitors Despite Daily Gains

Dow Jones
·
13 May

BUZZ-U.S. STOCKS ON THE MOVE-Hims & Hers Health, TXNM Energy, Forge Global

Reuters
·
13 May

Celanese Corp. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
09 May

Celanese Analysts Boost Their Forecasts After Upbeat Q1 Results

Benzinga
·
07 May

Celanese Is Maintained at Overweight by Keybanc

Dow Jones
·
07 May

Bausch + Lomb Gets European CE Mark for LuxLife Vision Intraocular Lens

MT Newswires Live
·
07 May

Bausch + Lomb’s LuxLife Intraocular Lens Gains European CE Mark Approval

TIPRANKS
·
07 May

Celanese Corp : Wells Fargo Raises Target Price to $45 From $40

THOMSON REUTERS
·
07 May